tiprankstipranks
Trending News
More News >
Relmada Therapeutics (RLMD)
NASDAQ:RLMD

Relmada Therapeutics (RLMD) Revenue

Compare
335 Followers

Relmada Therapeutics Revenue

Relmada Therapeutics had a revenue of 0.00 in the quarter ending Sep 30, 2024, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2024, Relmada Therapeutics had annual revenue of 0.00 with ― growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
17
Market Cap
$10.22M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 20240.00
Dec 31, 20230.00
Dec 31, 20220.00
Dec 31, 20210.00
Dec 31, 20200.00
Dec 31, 20190.00
Jun 30, 20190.00
Jun 30, 20180.00
Jun 30, 20170.00
Jun 30, 20160.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis